Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP1 | P53582 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | METAP2 | P50579 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6564247 | 0.98 | METAP1 (0.40) | METAP1CYP1A2ALDH1A1ALOX15METAP2 | |
| SCHEMBL29102100 | 0.85 | METAP1 (0.44) | METAP1CYP1A2METAP2SIGMAR1 | |
| SCHEMBL4761985 | 0.82 | MAPT (0.37) | ALDH1A1ALOX15PTPN1MAPT | |
| SCHEMBL24199 | 0.81 | CTSK (0.36) | ALDH1A1ALOX15 | |
| SCHEMBL22127323 | 0.80 | MAPT (0.41) | ALDH1A1ALOX15PTPN1MAPT | |
| SCHEMBL4761984 | 0.80 | MAPT (0.36) | ALDH1A1ALOX15PTPN1MAPT | |
| SCHEMBL28058465 | 0.79 | METAP1 (0.43) | METAP1CYP1A2METAP2SIGMAR1MAPT | |
| SCHEMBL4761987 | 0.79 | LIPA (0.38) | ALDH1A1ALOX15PTPN1MAPT | |
| SCHEMBL7634653 | 0.78 | CYP1A2 (0.48) | METAP1CYP1A2METAP2SIGMAR1 | |
| SCHEMBL24144 | 0.78 | ALDH1A1 (0.34) | ALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6172016-B1 | Fragrance materials | BUSH BOAKES ALLEN INC. | 2001-01-09 | — | — | US | claimed |
| EP-3142632-A1 | ANTIPERSPIRANT DEODORANT COSMETIC COMPOSITION HAVING DERMO-CALMING ACTION | Natura Cosméticos S.A. (BR) | 2017-03-22 | — | — | EP | disclosed |
| US-20150328099-A1 | Antitranspirant Deodorant Cosmetic Composition Having Dermo-Calming Action | NATURA COSMÉTICOS S.A (BR) | 2015-11-19 | — | — | US | disclosed |
| WO-2015172221-A1 | ANTIPERSPIRANT DEODORANT COSMETIC COMPOSITION HAVING DERMO-CALMING ACTION | Natura Cosméticos S.A. (BR) | 2015-11-19 | — | — | WO | disclosed |
| EP-2424829-B1 | OMEGA-CYCLOHEXYLALKAN-1-OLES AND USE THEREOF AS ANTIMICROBIAL ACTIVES TO COMBAT BODY ODOR | SYMRISE AG (DE) | 2015-01-07 | — | — | EP | disclosed |
| EP-2424829-B1 | OMEGA-CYCLOHEXYLALKAN-1-OLES AND USE THEREOF AS ANTIMICROBIAL ACTIVES TO COMBAT BODY ODOR | SYMRISE AG (DE) | 2015-01-07 | — | — | EP | disclosed |
| US-8623340-B2 | Omega-cyclohexylalkan-1-oles and use thereof as antimicrobial actives to combat body odor | SYMRISE AG (DE) | 2014-01-07 | — | — | US | disclosed |
| US-8623340-B2 | Omega-cyclohexylalkan-1-oles and use thereof as antimicrobial actives to combat body odor | SYMRISE AG (DE) | 2014-01-07 | — | — | US | disclosed |
| US-8623340-B2 | Omega-cyclohexylalkan-1-oles and use thereof as antimicrobial actives to combat body odor | SYMRISE AG (DE) | 2014-01-07 | — | — | US | disclosed |
| US-20120107258-A1 | OMEGA-CYCLOHEXYLALKAN-1-OLES AND USE THEREOF AS ANTIMICROBIAL ACTIVES TO COMBAT BODY ODOR | SYMRISE AG (DE) | 2012-05-03 | — | — | US | disclosed |
| US-20120107258-A1 | OMEGA-CYCLOHEXYLALKAN-1-OLES AND USE THEREOF AS ANTIMICROBIAL ACTIVES TO COMBAT BODY ODOR | SYMRISE AG (DE) | 2012-05-03 | — | — | US | disclosed |
| US-20120107258-A1 | OMEGA-CYCLOHEXYLALKAN-1-OLES AND USE THEREOF AS ANTIMICROBIAL ACTIVES TO COMBAT BODY ODOR | SYMRISE AG (DE) | 2012-05-03 | — | — | US | disclosed |
| EP-2424829-A2 | OMEGA-CYCLOHEXYLALKAN-1-OLES AND USE THEREOF AS ANTIMICROBIAL ACTIVES TO COMBAT BODY ODOR | Symrise AG (DE) | 2012-03-07 | — | — | EP | disclosed |
| WO-2009101216-A2 | OMEGA-CYCLOHEXYLALKAN-1-OLES AND USE THEREOF AS ANTIMICROBIAL ACTIVES TO COMBAT BODY ODOR | SYMRISE GMBH & CO. KG (DE) | 2009-08-20 | — | — | WO | disclosed |
| WO-2009101216-A2 | OMEGA-CYCLOHEXYLALKAN-1-OLES AND USE THEREOF AS ANTIMICROBIAL ACTIVES TO COMBAT BODY ODOR | SYMRISE GMBH & CO. KG (DE) | 2009-08-20 | — | — | WO | disclosed |
| US-6172016-B1 | Fragrance materials | BUSH BOAKES ALLEN INC. | 2001-01-09 | — | — | US | disclosed |
| US-6172016-B1 | Fragrance materials | BUSH BOAKES ALLEN INC. | 2001-01-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120107258-A1 | OMEGA-CYCLOHEXYLALKAN-1-OLES AND USE THEREOF AS ANTIMICROBIAL ACTIVES TO COMBAT BODY ODOR | ALOX12, ALOX15, ALOX15B | METAP1 1472/4885CYP1A2 319/4885ALDH1A1 123/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.